APO PHARM ApS: Financial statements 2015
CVR: 15226072
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 944,636 and a net result of DKK 2,192 compared with DKK -20,165 the year before. That is a decrease of 8.4% compared with the year before. Equity in the 2015 report amounted to DKK 173,132. The solvency ratio was 22.7%.
- Gross Profit
- DKK 944,636
- Profit/Loss
- DKK 2,192
- Equity
- DKK 173,132
- Total Assets
- DKK 764,244
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 945 t. | 2 t. | 173 t. | - |
| 2014 | - | 1 mio. | -20 t. | 171 t. | - |
| 2013 | - | 783 t. | -126 t. | 191 t. | - |
Official annual report
How creditworthy is APO PHARM ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.